Nuvalent Inc vs T Rowe Price Group Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while T Rowe Price Group Inc trades at $115.59 (market cap $25.14B). The key difference: T Rowe Price Group Inc is far larger — about 2.6× Nuvalent Inc's market cap, and T Rowe Price Group Inc pays a 4.43% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | TROW | |
|---|---|---|
Market Cap | $9.81B | $25.14B |
Sector | Technology | Financials |
52-Week High | $123.96 | $120.16 |
52-Week Low | $72.16 | $86.19 |
Enterprise Value | $8.52B | $21.85B |
Dividend Yield | — | 4.43% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →